Elad Gil | Startup Helper

Elad Gil is a serial entrepreneur, investor, operating executive, & advisor to private companies including Wish, Stripe, Square, Pinterest, OpenDoor, Instacart, Gusto, Checkr, Coinbase, & Airbnb

By Balthazar Malevolent

Elad Gil | Startup Helper

Elad holds a Ph.D. from MIT & has degrees in mathematics & biology from UCSD.

Previously, Elad was the VP of corporate strategy at Twitter, as well as ran various product teams (Geo, Search). He also spent many years at Google, where he started the mobile team & was involved in all aspects of getting the team up & running. He was involved with 3 acquisitions (including the Android team) & was the original product manager for Google Mobile Maps & other key mobile products. Prior to Google, Elad had product management & market seeding roles at a number of Silicon Valley companies.

Elad Gil is an angel investor who generally invests in young, emerging companies, with a tendency to do seed & Series A types of deals. Gil aims to assist portfolio companies focused on consumer web, mobile, geo, search, & advertising/monetization through his work as an entrepreneur at Mixer Labs, which was acquired by Twitter. His prior work also includes positions at Google, Twitter, & other startups. Gil seeks to help portfolio companies on product & business development deals.

Elad Gil co-founded Color Genomics among others like Taylor Sittler, Nish Bhat, & Othman Laraki, a native of Casablanca, Morocco, who serves as company’s CEO, in Burlingame, California. In 2015, Color Genomics accepted an initial $15 million in funding. It raised an additional $45 million in September 2016. Katie Jacobs Stanton became the CMO of Color Genomics in 2016, & Jill Hagenkord became the Chief Medical Officer.

Color Genomic’s purpose is to surge availability for genetic testing. Part of this is to develop access to tests for minorities, in order to better understanding non-Caucasian gene variants. The original cost for the test was approximately 10% of the cost of testing through traditional companies. Later on, the company offered a discounted price for the family members of those who test positive for inherited mutations. In 2017, Color Genomics began taking health insurance for the Color Test.

The technological startup companies have also begun adding Color Genomics testing to their medical packages. The University of Washington & Color Genomics released a widely obtainable database of variants in 27 breast cancer genes based on the given samples from over 70 years old women who have never had breast cancer. The samples were gathered from samples given to the Women’s Health Initiative between 1993 & 2005. In 2018, Color added a new health area, medication response, to evaluate genes related with commonly prescribed prescriptions, & report on how those genes can affect how individuals process & react to those treatments. Color grew its offering to include a $249 test for genetic heart health. The test examines 30 genes to observe for risk of a wide range of genetic heart conditions, including cardiomyopathies, cardiac arrhythmias, & arteriopathies.

The NIH recognized Color funding on September 25, 2018, for their All of Us Research program.

At least 30 startups in Gil’s portfolio have become 'unicorn' companies. Some of the early checks he wrote to startups that are now raising serious venture dollars, including Character.AI, backed this year by Andreessen Horowitz, Perplexity.AI, backed by NEA & Harvey, backed by Sequoia Capital.

Elad Gil
No results